FDA.reportPublic FDA data

SORBITOL

Substance profile for UNII 506T60A25R, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for SORBITOL
Structure render from PubChem CID 5780

Substance Identity#

UNII
506T60A25R
Preferred term
SORBITOL
Registry number
50-70-4
EC number
200-061-5
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C6H14O6
Chemical structure for SORBITOL
Structure render from PubChem CID 5780

Chemical And Database Identifiers#

InChIKey
FBPFZTCFMRRESA-JGWLITMVSA-N
SMILES
OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO
RxCUI
9945
PubChem
5780
NCIt
C29462
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound5780https://pubchem.ncbi.nlm.nih.gov/compound/5780
PubChem InChIKey SearchFBPFZTCFMRRESA-JGWLITMVSA-Nhttps://pubchem.ncbi.nlm.nih.gov/#query=FBPFZTCFMRRESA-JGWLITMVSA-N
RxNorm9945https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=9945
NCI ThesaurusC29462https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29462
FDA Substance Registration System506T60A25Rhttps://precision.fda.gov/uniisearch/srs/unii/506T60A25R
European Community number200-061-5https://commonchemistry.cas.org/results?q=200-061-5

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
SORBITOLINACTIVE INGREDIENT506T60A25RDrug Facts5
SORBITOLINACTIVE INGREDIENT506T60A25RDrug Facts5
SORBITOLINACTIVE INGREDIENT506T60A25RKmart Corporation Children's Mucus Relief Drug Facts4
SORBITOLINACTIVE INGREDIENT506T60A25RTRIACIN-C (Triprolidine HCl, Pseudoephedrine HCl, and Codeine Phosphate Syrup)4
SORBITOLINACTIVE INGREDIENT506T60A25R51b36e7c-a6ce-42c8-99f4-84ceb6550c334
SORBITOLINACTIVE INGREDIENT506T60A25Re84a6273-30aa-4636-ab2d-003afd43fad24
SORBITOLINACTIVE INGREDIENT506T60A25R6c06ffdc-5f9c-42c3-98d4-c3ddd0c1a3d94
SORBITOLINACTIVE INGREDIENT506T60A25R5eb982c8-ebb0-400a-916d-ec902b6aa3c34
SORBITOLINACTIVE INGREDIENT506T60A25Ra7b53622-95c0-4799-ae66-d634f24c77944
SORBITOLINACTIVE INGREDIENT506T60A25RCVS Pharmacy, Inc. Tussin CF Drug Facts5
SORBITOLINACTIVE INGREDIENT506T60A25RBJWC Nicotine Gum Drug Facts4
SORBITOLINACTIVE INGREDIENT506T60A25RSuperValu Inc. Nicotine Gum Drug Facts4
SORBITOLINACTIVE INGREDIENT506T60A25RSupervalu Inc. Nicotine Gum Drug Facts4
SORBITOLINACTIVE INGREDIENT506T60A25RThese highlights do not include all the information needed to use Oxycodone Hydrochloride safely and effectively. See full prescribing information for Oxycodone Hydrochloride. Oxycodone Hydrochloride (Oxycodone Hydrochloride) SOLUTION for ORAL use. Initial U.S. Approval: 19504
SORBITOLINACTIVE INGREDIENT506T60A25RBJWC Nicotine Polacrilex Gum 2 mg (nicotine) Drug Facts4
SORBITOLINACTIVE INGREDIENT506T60A25RThese highlights do not include all the information needed to use oxcarbazepine oral suspension, USP safely and effectively. See full prescribing information for oxcarbazepine oral suspension, USP. Oxcarbazepine oral suspension, USP for oral administration Initial U.S. Approval: 20008
SORBITOLINACTIVE INGREDIENT506T60A25Rc40be43e-3da9-441b-8cde-82a471b940124
SORBITOLINACTIVE INGREDIENT506T60A25RDrug Facts7
SORBITOLINACTIVE INGREDIENT506T60A25RTheophylline Oral Solution4
SORBITOLINACTIVE INGREDIENT506T60A25RFuradantin ® (nitrofurantoin) Oral Suspension13
SORBITOLINACTIVE INGREDIENT506T60A25RDrug Facts5
SORBITOLINACTIVE INGREDIENT506T60A25RRugby ® NASAL DECONGESTANT LIQUID1000
SORBITOLINACTIVE INGREDIENT506T60A25RThese highlights do not include all the information needed to use Levetiracetam Oral Solution, USP safely and effectively. See full prescribing information for Levetiracetam Oral Solution, USP. Levetiracetam Oral Solution, USP Initial U.S. Approval: 19999
SORBITOLINACTIVE INGREDIENT506T60A25RDocusate Sodium 250mg11
sorbitolINACTIVE INGREDIENT506T60A25RDONNATAL ELIXIR grape flavor 1 pint7
sorbitolINACTIVE INGREDIENT506T60A25RDonnatal Elixir 4oz grape flavor7
sorbitolINACTIVE INGREDIENT506T60A25RDonnatal Elixir Mint 16 oz4
SORBITOLINACTIVE INGREDIENT506T60A25RDrug Facts:4
SORBITOLINACTIVE INGREDIENT506T60A25RDrug Facts5
SORBITOLINACTIVE INGREDIENT506T60A25RPediaCare Single Dose Fever Reducer5
SORBITOLINACTIVE INGREDIENT506T60A25RKids Cough and Fever Relief4
SORBITOLINACTIVE INGREDIENT506T60A25RKids Cold and Mucus Relief9
SORBITOLINACTIVE INGREDIENT506T60A25ROral Defense Fluoride Rinse12
SORBITOLINACTIVE INGREDIENT506T60A25RThese highlights do not include all the information needed to use Clindesse safely and effectively. See full prescribing information for Clindesse. Clindesse ® (clindamycin phosphate) Vaginal Cream, 2% For intravaginal use only. Initial U.S. Approval: 197210
SORBITOLINACTIVE INGREDIENT506T60A25RToothpaste5
SORBITOLINACTIVE INGREDIENT506T60A25RDrug Facts5
SORBITOLINACTIVE INGREDIENT506T60A25RDRUG FACTS5
SORBITOLINACTIVE INGREDIENT506T60A25RRugby Extra Strength Stool Softener Laxative1000
SORBITOLINACTIVE INGREDIENT506T60A25R51b7d92e-e8e5-4e9d-916c-02e6b35ad3b14
SORBITOLINACTIVE INGREDIENT506T60A25RSpearmint and Peppermint PLAQUE A WAY Fluoride Anticavity Toothpaste Gentle Formula4
SORBITOLINACTIVE INGREDIENT506T60A25R5dcd492f-cef1-41ba-b5d2-c79c31601f636
SORBITOLINACTIVE INGREDIENT506T60A25RAmantadine Hydrochloride Capsules, USP Rx only5
SORBITOLINACTIVE INGREDIENT506T60A25RLeader Nighttime Sleep Aid Maximum Strength5
SORBITOLINACTIVE INGREDIENT506T60A25ROral Defense Mouth Rinse17
SORBITOLINACTIVE INGREDIENT506T60A25RThese highlights do not include all the information needed to use valproic acid safely and effectively. See full prescribing information for valproic acid. Valproic Acid Oral Solution, USP Initial U.S. Approval: 19784
SORBITOLINACTIVE INGREDIENT506T60A25RThese highlights do not include all the information needed to use MICARDIS safely and effectively. See full prescribing information for MICARDIS. MICARDIS ® (telmisartan) Tablets Initial U.S. Approval: 19985
SORBITOLINACTIVE INGREDIENT506T60A25RDawnmist toothpaste4
SORBITOLINACTIVE INGREDIENT506T60A25RSun Diffusing Protector SPF 156
SORBITOLINACTIVE INGREDIENT506T60A25RMoisturizing Sunscreen SPF 30+6
SORBITOLINACTIVE INGREDIENT506T60A25RDrug Facts5
sorbitolINACTIVE INGREDIENT506T60A25RThese highlights do not include all the information needed to use risperidone safely and effectively. See full prescribing information for risperidone. Risperidone Oral Solution USP Initial U.S. Approval: 19939
SORBITOLINACTIVE INGREDIENT506T60A25RADVANCED FLUORIDE ANTICAVITY TOOTHPASTE5
SORBITOLINACTIVE INGREDIENT506T60A25RRx only4
SORBITOLINACTIVE INGREDIENT506T60A25RLevel Mint Anticavity Toothpaste9
SORBITOLINACTIVE INGREDIENT506T60A25RLEVEL WINTERMINT FIVE WHITENING FORMULA ANTICAVITY TOOTHPASTE perfect your smile5
SORBITOLINACTIVE INGREDIENT506T60A25RLEVEL HERBAL MINT FIVE SENSITIVE FORMULA ANTICAVITY TOOTHPASTE perfect your smile4
SORBITOLINACTIVE INGREDIENT506T60A25Rdrug facts10
SorbitolINACTIVE INGREDIENT506T60A25RDrug Facts4
SORBITOLINACTIVE INGREDIENT506T60A25RRite Aid Protec-Health Anti-Cavity, Anti-Gingivitis Toothpaste6
SORBITOLINACTIVE INGREDIENT506T60A25RAcne Serum4
SorbitolINACTIVE INGREDIENT506T60A25RLIFElabs, a Division of Atico International USA, INC.5
SORBITOLINACTIVE INGREDIENT506T60A25RDrug Facts4
SORBITOLINACTIVE INGREDIENT506T60A25RDrug Facts4
SORBITOLINACTIVE INGREDIENT506T60A25RDrug Facts4
SORBITOLINACTIVE INGREDIENT506T60A25RLITHIUM CARBONATE Extended Release Tablets USP, 300 mg6
SORBITOLINACTIVE INGREDIENT506T60A25RDrug Facts4
SORBITOLINACTIVE INGREDIENT506T60A25RCarton and bottle labelling4
SorbitolINACTIVE INGREDIENT506T60A25RTRIAMCINOLONE ACETONIDE CREAM [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3962
SORBITOLINACTIVE INGREDIENT506T60A25RONDANSETRON TABLET, ORALLY DISINTEGRATING [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3925
sorbitolINACTIVE INGREDIENT506T60A25RZONALON (DOXEPIN HYDROCHLORIDE) CREAM [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3721
sorbitolINACTIVE INGREDIENT506T60A25RAMITIZA (LUBIPROSTONE) CAPSULE, GELATIN COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3170
SORBITOLINACTIVE INGREDIENT506T60A25RFLECTOR (DICLOFENAC EPOLAMINE ) PATCH [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3142
SORBITOLINACTIVE INGREDIENT506T60A25RZIPSOR (DICLOFENAC POTASSIUM) CAPSULE, LIQUID FILLED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS]2043
SORBITOLINACTIVE INGREDIENT506T60A25RDEPAKENE (VALPROIC ACID) SOLUTION DEPAKENE (VALPROIC ACID) CAPSULE, LIQUID FILLED [ABBVIE INC.]1541
SORBITOLINACTIVE INGREDIENT506T60A25RHYOSCYAMINE SULFATE TABLET [BRYANT RANCH PREPACK]1001
SORBITOLINACTIVE INGREDIENT506T60A25RISONIAZID SOLUTION [BRYANT RANCH PREPACK]1001
SORBITOLINACTIVE INGREDIENT506T60A25RFLECTOR (DICLOFENAC EPOLAMINE) PATCH [BRYANT RANCH PREPACK]1000
SORBITOLINACTIVE INGREDIENT506T60A25RLIDOCAINE PATCH [BRYANT RANCH PREPACK]1000
SORBITOLINACTIVE INGREDIENT506T60A25RPROLIA (DENOSUMAB) INJECTION [AMGEN INC]147
SORBITOLINACTIVE INGREDIENT506T60A25RXGEVA (DENOSUMAB) INJECTION [AMGEN INC]147
SORBITOLINACTIVE INGREDIENT506T60A25RNEUPOGEN (FILGRASTIM) INJECTION, SOLUTION [AMGEN INC]144
SORBITOLINACTIVE INGREDIENT506T60A25RNEULASTA (PEGFILGRASTIM) KIT NEULASTA (PEGFILGRASTIM) INJECTION [AMGEN INC]126
SORBITOLINACTIVE INGREDIENT506T60A25RISENTRESS (RALTEGRAVIR) TABLET, FILM COATED ISENTRESS (RALTEGRAVIR) TABLET, CHEWABLE ISENTRESS (RALTEGRAVIR) GRANULE, FOR SUSPENSION [MERCK SHARP & DOHME CORP.]49
SORBITOLINACTIVE INGREDIENT506T60A25RREVATIO (SILDENAFIL CITRATE) TABLET, FILM COATED REVATIO (SILDENAFIL CITRATE) INJECTION, SOLUTION REVATIO (SILDENAFIL CITRATE) POWDER, FOR SUSPENSION [PFIZER LABORATORIES DIV PFIZER INC]33
sorbitolINACTIVE INGREDIENT506T60A25RTAMIFLU (OSELTAMIVIR PHOSPHATE) POWDER, FOR SUSPENSION TAMIFLU (OSELTAMIVIR PHOSPHATE) CAPSULE [GENENTECH, INC.]30
sorbitolINACTIVE INGREDIENT506T60A25RCELLCEPT (MYCOPHENOLATE MOFETIL) TABLET, FILM COATED CELLCEPT (MYCOPHENOLATE MOFETIL) CAPSULE CELLCEPT (MYCOPHENOLATE MOFETIL HYDROCHLORIDE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION CELLCEPT (MYCOPHENOLATE MOFETIL) POWDER, FOR SUSPENSION [GENENTECH, INC.]26
sorbitolINACTIVE INGREDIENT506T60A25RVIMPAT (LACOSAMIDE) TABLET, FILM COATED VIMPAT (LACOSAMIDE) KIT VIMPAT (LACOSAMIDE) INJECTION VIMPAT (LACOSAMIDE) SOLUTION [UCB, INC.]26
SORBITOLINACTIVE INGREDIENT506T60A25RBANZEL (RUFINAMIDE) TABLET, FILM COATED BANZEL (RUFINAMIDE) SUSPENSION [EISAI INC.]24
SORBITOLINACTIVE INGREDIENT506T60A25RACNE TREATMENT KIT PRESCRIPTION CARE (BENZOYL PEROXIDE) KIT [BLUE CROSS LABORATORIES]22
SORBITOLINACTIVE INGREDIENT506T60A25RUP AND UP DM MAX COUGH PLUS CHEST CONGESTION (DEXTROMETHORPHAN HBR, GUAIFENESIN) SUSPENSION [TARGET CORPORATION]22
SORBITOLINACTIVE INGREDIENT506T60A25RREBETOL (RIBAVIRIN) CAPSULE REBETOL (RIBAVIRIN) LIQUID [MERCK SHARP & DOHME CORP.]21
sorbitolINACTIVE INGREDIENT506T60A25RCITALOPRAM HYDROBROMIDE SOLUTION [SILARX PHARMACEUTICALS, INC]20
SORBITOLINACTIVE INGREDIENT506T60A25ROXYCODONE HYDROCHLORIDE SOLUTION [LANNETT COMPANY, INC.]20
SORBITOLINACTIVE INGREDIENT506T60A25RTRILEPTAL (OXCARBAZEPINE) TABLET, FILM COATED TRILEPTAL (OXCARBAZEPINE) SUSPENSION [NOVARTIS PHARMACEUTICALS CORPORATION]20
SORBITOLINACTIVE INGREDIENT506T60A25RVIBRAMYCIN MONOHYDRATE (DOXYCYCLINE) POWDER, FOR SUSPENSION VIBRAMYCIN CALCIUM (DOXYCYCLINE CALCIUM) SYRUP VIBRAMYCIN HYCLATE (DOXYCYCLINE HYCLATE) CAPSULE VIBRA-TABS (DOXYCYCLINE HYCLATE) TABLET, FILM COATED [PFIZER LABORATORIES DIV PFIZER INC]20
SORBITOLINACTIVE INGREDIENT506T60A25RCYCLOSPORINE CAPSULE [EON LABS, INC.]19
SORBITOLINACTIVE INGREDIENT506T60A25RMORPHINE SULFATE SOLUTION, CONCENTRATE [LANNETT COMPANY, INC.]19
SORBITOLINACTIVE INGREDIENT506T60A25RCITY SUNSCREEN SERUM BROAD SPECTRUM SPF 30 SUPERGOOP (HOMOSALATE, OCTISALATE, AVOBENZENE, OCTOCRYLENE) CREAM [TAYLOR JAMES, LTD.]18
sorbitolINACTIVE INGREDIENT506T60A25RLEVETIRACETAM SOLUTION [SILARX PHARMACEUTICALS, INC]18
SORBITOLINACTIVE INGREDIENT506T60A25RLEXAPRO (ESCITALOPRAM OXALATE) TABLET, FILM COATED LEXAPRO (ESCITALOPRAM OXALATE) SOLUTION [FOREST LABORATORIES, INC.]18
sorbitolINACTIVE INGREDIENT506T60A25RNAPROSYN (NAPROXEN) TABLET EC-NAPROSYN (NAPROXEN) TABLET, DELAYED RELEASE NAPROSYN (NAPROXEN) SUSPENSION ANAPROX (NAPROXEN SODIUM) TABLET ANAPROX DS (NAPROXEN SODIUM) TABLET [GENENTECH, INC.]18
sorbitolINACTIVE INGREDIENT506T60A25RSIMPONI (GOLIMUMAB) INJECTION, SOLUTION [JANSSEN BIOTECH, INC.]18
SORBITOLINACTIVE INGREDIENT506T60A25RTEGRETOL (CARBAMAZEPINE) TABLET, CHEWABLE TEGRETOL (CARBAMAZEPINE) SUSPENSION TEGRETOL (CARBAMAZEPINE) TABLET TEGRETOL XR (CARBAMAZEPINE) TABLET, EXTENDED RELEASE [NOVARTIS PHARMACEUTICALS CORPORATION]18
SORBITOLINACTIVE INGREDIENT506T60A25RHYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX EXTENDED-RELEASE (HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX) SUSPENSION, EXTENDED RELEASE [ARISTOS PHAMACEUTICALS, INC.]17
SORBITOLINACTIVE INGREDIENT506T60A25RPROQUAD (MEASLES, MUMPS, RUBELLA AND VARICELLA VIRUS VACCINE LIVE) INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION [MERCK SHARP & DOHME CORP.]17
SORBITOLINACTIVE INGREDIENT506T60A25RRISPERIDONE SOLUTION [QUALITEST PHARMACEUTICALS]17
SORBITOLINACTIVE INGREDIENT506T60A25RSANDIMMUNE (CYCLOSPORINE) CAPSULE, LIQUID FILLED SANDIMMUNE (CYCLOSPORINE) INJECTION SANDIMMUNE (CYCLOSPORINE) SOLUTION [NOVARTIS PHARMACEUTICALS CORPORATION]17
SORBITOLINACTIVE INGREDIENT506T60A25RZIAGEN (ABACAVIR SULFATE) TABLET, FILM COATED ZIAGEN (ABACAVIR SULFATE) SOLUTION [VIIV HEALTHCARE COMPANY]17
SORBITOLINACTIVE INGREDIENT506T60A25RARISTOSPAN (TRIAMCINOLONE HEXACETONIDE) INJECTION, SUSPENSION [SANDOZ INC]16
SORBITOLINACTIVE INGREDIENT506T60A25RASTEPRO (AZELASTINE HYDROCHLORIDE) SPRAY, METERED [MEDA PHARMACEUTICALS INC.]16
sorbitolINACTIVE INGREDIENT506T60A25RBROTAPP (BROMPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE) LIQUID [SILARX PHARMACEUTICALS, INC]16
SORBITOLINACTIVE INGREDIENT506T60A25RM-M-R II (MEASLES, MUMPS, AND RUBELLA VIRUS VACCINE LIVE) INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION [MERCK SHARP & DOHME CORP.]16
sorbitolINACTIVE INGREDIENT506T60A25ROXYBUTYNIN CHLORIDE SYRUP [SILARX PHARMACEUTICALS, INC]16
SORBITOLINACTIVE INGREDIENT506T60A25RSPORANOX (ITRACONAZOLE) SOLUTION [JANSSEN PHARMACEUTICALS, INC.]16
SORBITOLINACTIVE INGREDIENT506T60A25RVALPROIC ACID SOLUTION [HI-TECH PHARMACAL CO., INC.]16
SORBITOLINACTIVE INGREDIENT506T60A25RVALPROIC ACID SOLUTION [QUALITEST PHARMACEUTICALS]16
SORBITOLINACTIVE INGREDIENT506T60A25RESCITALOPRAM OXALATE (ESCITALOPRAM) SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC]15
SORBITOLINACTIVE INGREDIENT506T60A25RRISPERIDONE TABLET, ORALLY DISINTEGRATING [PAR PHARMACEUTICAL COMPANIES, INC.]15
sorbitolINACTIVE INGREDIENT506T60A25RSILTUSSIN SA (GUAIFENESIN) LIQUID [SILARX PHARMACEUTICALS, INC]15
SORBITOLINACTIVE INGREDIENT506T60A25RZOFRAN (ONDANSETRON HYDROCHLORIDE) SOLUTION ZOFRAN ODT (ONDANSETRON HYDROCHLORIDE) TABLET, ORALLY DISINTEGRATING ZOFRAN (ONDANSETRON HYDROCHLORIDE) TABLET, FILM COATED [GLAXOSMITHKLINE LLC]15

Inactive Ingredient Database#

Browse recovered IID releases and source provenance.

Current IID rows for UNII 506T60A25R page 1 of 1 · 44 matching rows.

Ingredient, UNII, CAS table
IngredientUNIICASDosage formRoutePotencyMaximum daily exposure
SORBITOL506T60A25R50704GUM, CHEWINGBUCCAL5110 mg
SORBITOL506T60A25R50704PASTEDENTAL14.6 %w/w
SORBITOL506T60A25R50704PASTE, DENTIFRICEDENTAL14 %w/w
SORBITOL506T60A25R50704INJECTIONINTRA-ARTICULAR45 %w/v
SORBITOL506T60A25R50704INJECTIONINTRALESIONAL45 %w/v
SORBITOL506T60A25R50704INJECTIONINTRAMUSCULARNA
SORBITOL506T60A25R50704INJECTIONINTRASYNOVIAL45 %w/v
SORBITOL506T60A25R50704INJECTIONINTRAVENOUS1276 mg
SORBITOL506T60A25R50704INJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONINTRAVENOUS1.04 %w/v
SORBITOL506T60A25R50704INJECTION, SOLUTIONINTRAVENOUS4050 mg
SORBITOL506T60A25R50704SOLUTIONNASAL25 mg/1ml
SORBITOL506T60A25R50704SPRAYNASAL49 mg
SORBITOL506T60A25R50704SOLUTIONOPHTHALMIC6 mg
SORBITOL506T60A25R50704SOLUTION/ DROPSOPHTHALMIC0.25 %w/v
SORBITOL506T60A25R50704CAPSULEORAL1111 mg
SORBITOL506T60A25R50704CONCENTRATEORAL600 mg/1ml
SORBITOL506T60A25R50704ELIXIRORAL833.3 mg
SORBITOL506T60A25R50704GUM, CHEWINGORAL6168 mg
SORBITOL506T60A25R50704LIQUIDORAL53460 mg
SORBITOL506T60A25R50704POWDERORAL36000 mg
SORBITOL506T60A25R50704POWDER, FOR SUSPENSIONORAL12000 mg
SORBITOL506T60A25R50704SOLUTIONORAL29268 mg
SORBITOL506T60A25R50704SOLUTION, CONCENTRATEORAL300 mg/1ml
SORBITOL506T60A25R50704SUSPENSIONORAL45000 mg
SORBITOL506T60A25R50704SYRUPORAL4370 mg/5ml
SORBITOL506T60A25R50704TABLETORAL337.28 mg
SORBITOL506T60A25R50704TABLET, CHEWABLEORAL3555 mg
SORBITOL506T60A25R50704TABLET, COATEDORAL12.96 mg
SORBITOL506T60A25R50704TABLET, DELAYED RELEASEORAL0.01 mg
SORBITOL506T60A25R50704TABLET, EXTENDED RELEASEORAL428 mg
SORBITOL506T60A25R50704TABLET, FILM COATEDORAL5 mg
SORBITOL506T60A25R50704TABLET, ORALLY DISINTEGRATINGORAL7 mg
SORBITOL506T60A25R50704SUSPENSIONRECTAL46.18 %w/v
SORBITOL506T60A25R50704INJECTIONSUBCUTANEOUS4.7 %w/v
SORBITOL506T60A25R50704INJECTION, SOLUTIONSUBCUTANEOUS4.7 %w/v
SORBITOL506T60A25R50704TABLETSUBLINGUAL50.5 mg
SORBITOL506T60A25R50704AEROSOL, FOAMTOPICAL4.95 %w/w
SORBITOL506T60A25R50704CREAMTOPICAL36.8 %w/w
SORBITOL506T60A25R50704CREAM, AUGMENTEDTOPICAL15 %w/w
SORBITOL506T60A25R50704EMULSIONTOPICAL7 %w/w
SORBITOL506T60A25R50704LIQUIDTOPICAL1 %w/w
SORBITOL506T60A25R50704LOTIONTOPICAL10.7 %w/w
SORBITOL506T60A25R50704OINTMENTTOPICAL10 %w/w
SORBITOL506T60A25R50704SYSTEMTOPICAL6300 mg